Transdermal siRNA-TGFβ1-337 patch for hypertrophic scar treatment

Matrix Biology

Volumn 32, Issue 5, 2013, Pages 265-276

  Zhao, Rui ^a   Yan, Qitao ^a   Huang, Haili ^b   Lv, Jingye ^a   Ma, Wenli ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hypertrophic scar; SiRNA; TGF 1; Transdermal patch

Indexed keywords

COLLAGEN; SMALL INTERFERING RNA; SMALL INTERFERING RNA TRANSFORMING GROWTH FACTOR BETA1 337; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; HYDROGEL; HYPERTROPHIC SCAR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSDERMAL PATCH;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CICATRIX, HYPERTROPHIC; COLLAGEN TYPE I; FIBROBLASTS; HUMANS; MICE; MICE, NUDE; PRIMARY CELL CULTURE; RNA, SMALL INTERFERING; SKIN; SKIN TRANSPLANTATION; TRANSDERMAL PATCH; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS; WOUND HEALING;

ANIMALIA; MUS MUSCULUS;

EID: 84879602821     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.02.004     Document Type: Article

References (44)

1. Ahn J.Y., Park S., Yun Y.S., Song J.Y. Inhibition of type III TGF-beta receptor aggravates lung fibrotic process. Biomed. Pharmacother. 2010, 64:472-476.
2. Basler K., Edlund T., Jessell T.M., Yamada T. Control of cell pattern in the neural tube: regulation of cell differentiation by dorsalin-1, a novel TGF beta family member. Cell 1993, 73:687-702.
3. Bellemare J., Roberge C.J., Bergeron D., Lopez-Valle C.A., Roy M., Moulin V.J. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J. Pathol. 2005, 206:1-8.
4. Bonniaud P., Margetts P.J., Kolb M., Schroeder J.A., Kapoun A.M., Damm D., Murphy A., Chakravarty S., Dugar S., Higgins L., Protter A.A., Gauldie J. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am. J. Respir. Crit. Care Med. 2005, 171:889-898.
5. Border W.A., Okuda S., Languino L.R., Sporn M.B., Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990, 346:371-374.
6. Broekelmann T.J., Limper A.H., Colby T.V., McDonald J.A. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:6642-6646.
7. Castilla A., Prieto J., Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N. Engl. J. Med. 1991, 324:933-940.
8. Chen W., Fu X., Ge S., Sun T., Zhou G., Jiang D., Sheng Z. Ontogeny of expression of transforming growth factor-beta and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair Regen. 2005, 13:68-75.
9. Chipev C.C., Simman R., Hatch G., Katz A.E., Siegel D.M., Simon M. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ. 2000, 7:166-176.
10. Connor T.B., Roberts A.B., Sporn M.B., Danielpour D., Dart L.L., Michels R.G., de Bustros S., Enger C., Kato H., Lansing M., et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J. Clin. Invest. 1989, 83:1661-1666.
11. Daniels C.E., Wilkes M.C., Edens M., Kottom T.J., Murphy S.J., Limper A.H., Leof E.B. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 2004, 114:1308-1316.
12. Diez-Marques L., Ortega-Velazquez R., Langa C., Rodriguez-Barbero A., Lopez-Novoa J.M., Lamas S., Bernabeu C. Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis. Biochim. Biophys. Acta 2002, 1587:36-44.
13. Dorfmuller M. Psychological management and after-care of severely burned patients. Unfallchirurg 1995, 98:213-217.
14. Ehrlich H.P., Kelley S.F. Hypertrophic scar: an interruption in the remodeling of repair - a laser Doppler blood flow study. Plast. Reconstr. Surg. 1992, 90:993-998.
15. Ghahary A., Shen Y.J., Scott P.G., Tredget E.E. Immunolocalization of TGF-beta 1 in human hypertrophic scar and normal dermal tissues. Cytokine 1995, 7:184-190.
16. Juarez P., Vilchis-Landeros M.M., Ponce-Coria J., Mendoza V., Hernandez-Pando R., Bobadilla N.A., Lopez-Casillas F. Soluble betaglycan reduces renal damage progression in db/db mice. Am. J. Physiol. Renal Physiol. 2007, 292:F321-F329.
17. Kane C.J., Hebda P.A., Mansbridge J.N., Hanawalt P.C. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J. Cell. Physiol. 1991, 148:157-173.
18. Kim B.C., Kim H.T., Park S.H., Cha J.S., Yufit T., Kim S.J., Falanga V. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J. Cell. Physiol. 2003, 195:331-336.
19. Leask A., Abraham D.J., Finlay D.R., Holmes A., Pennington D., Shi-Wen X., Chen Y., Venstrom K., Dou X., Ponticos M., Black C., Bernabeu C., Jackman J.K., Findell P.R., Connolly M.K. Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum. 2002, 46:1857-1865.
20. Marquez-Aguirre A., Sandoval-Rodriguez A., Gonzalez-Cuevas J., Bueno-Topete M., Navarro-Partida J., Arellano-Olivera I., Lucano-Landeros S., Armendariz-Borunda J. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats. J. Gene Med. 2009, 11:207-219.
21. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
22. McCartney-Francis N.L., Frazier-Jessen M., Wahl S.M. TGF-beta: a balancing act. Int. Rev. Immunol. 1998, 16:553-580.
23. McCormick L.L., Zhang Y., Tootell E., Gilliam A.C. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J. Immunol. 1999, 163:5693-5699.
24. Nakano T., Scott P.G. Purification and characterization of a gelatinase produced by fibroblasts from human gingiva. Biochem. Cell Biol. 1986, 64:387-393.
25. Pastar I., Stojadinovic O., Krzyzanowska A., Barrientos S., Stuelten C., Zimmerman K., Blumenberg M., Brem H., Tomic-Canic M. Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol. Med. 2010, 16:92-101.
26. Pierce G.F., Vande Berg J., Rudolph R., Tarpley J., Mustoe T.A. Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am. J. Pathol. 1991, 138:629-646.
27. Robert R., Meyer W., Bishop S., Rosenberg L., Murphy L., Blakeney P. Disfiguring burn scars and adolescent self-esteem. Burns 1999, 25:581-585.
28. Roberts A.B., Sporn M.B. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol. Reprod. Dev. 1992, 32:91-98.
29. Rodriguez-Pena A., Prieto M., Duwel A., Rivas J.V., Eleno N., Perez-Barriocanal F., Arevalo M., Smith J.D., Vary C.P., Bernabeu C., Lopez-Novoa J.M. Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction. Nephrol. Dial. Transplant. 2001, 16(Suppl. 1):34-39.
30. Rudolph R. Wide spread scars, hypertrophic scars, and keloids. Clin. Plast. Surg. 1987, 14:253-260.
31. Shah M., Foreman D.M., Ferguson M.W. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992, 339:213-214.
32. Shah M., Foreman D.M., Ferguson M.W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 1995, 108(Pt 3):985-1002.
33. Sheridan R.L. Burn care: results of technical and organizational progress. JAMA 2003, 290:719-722.
34. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
35. Sullivan K.M., Lorenz H.P., Meuli M., Lin R.Y., Adzick N.S. A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J. Pediatr. Surg. 1995, 30:198-202. (discussion 202-193).
36. Taal L., Faber A.W. Posttraumatic stress and maladjustment among adult burn survivors 1 to 2years postburn. Part II: the interview data. Burns 1998, 24:399-405.
37. Tredget E.E., Nedelec B., Scott P.G., Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg. Clin. North Am. 1997, 77:701-730.
38. Tredget E.E., Shankowsky H.A., Pannu R., Nedelec B., Iwashina T., Ghahary A., Taerum T.V., Scott P.G. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast. Reconstr. Surg. 1998, 102:1317-1328. (discussion 1329-1330).
39. Tredget E.E., Yang L., Delehanty M., Shankowsky H., Scott P.G. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J. Interferon Cytokine Res. 2006, 26:179-189.
40. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., Sporn M.B. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:5788-5792.
41. Wang J., Jiao H., Stewart T.L., Shankowsky H.A., Scott P.G., Tredget E.E. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen. 2007, 15:530-539.
42. Woo S.H., Seul J.H. Optimizing the correction of severe postburn hand deformities by using aggressive contracture releases and fasciocutaneous free-tissue transfers. Plast. Reconstr. Surg. 2001, 107:1-8.
43. Yang L., Scott P.G., Giuffre J., Shankowsky H.A., Ghahary A., Tredget E.E. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab. Invest. 2002, 82:1183-1192.
44. Zhang Y., McCormick L.L., Gilliam A.C. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J. Invest. Dermatol. 2003, 121:713-719.